⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Pomerantz LLP Issues Reminder to Investors in Vistagen Therapeutics, Inc. of Class Action Lawsuit – VTGN
accessnewswire.com
VTGN
Pomerantz LLP Issues Reminder to Investors in Vistagen Therapeutics, Inc. of Class Action Filing – VTGN
accessnewswire.com
VTGN
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Issues Reminder to Investors in Vistagen Therapeutics, Inc. of Class Action Filing – VTGN
accessnewswire.com
VTGN
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
VTGN
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
globenewswire.com
VTGN
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Issues Reminder to Investors in Vistagen Therapeutics, Inc. of Class Action – VTGN
accessnewswire.com
VTGN
Pomerantz LLP Issues Reminder to Investors in Vistagen Therapeutics, Inc. of Class Action – VTGN
accessnewswire.com
VTGN
VTGN SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026
globenewswire.com
VTGN